DEA Judge Sets August 17 Deadline. Here’s What Happens Next in Marijuana Rescheduling

After more than two weeks of testimony from regulators, researchers, healthcare professionals, industry participants, and other designated parties, the Drug Enforcement Administration’s marijuana rescheduling proceeding has shifted from public hearings to post-hearing legal briefing.

On July 16, Chief Administrative Law Judge Derek C. Julius issued a procedural order giving designated parties until Aug. 17 to submit optional post-hearing briefs and proposed corrections to the hearing transcript.

While the order does not establish when a final decision will be made, it provides the clearest roadmap yet for the next stage of one of the most closely watched federal cannabis proceedings in decades.

August 17 Is an Important Deadline—But Not the Final Decision

The Aug. 17 deadline marks the end of the post-hearing submission period, not the conclusion of the rescheduling process.

Judge Julius ordered that designated parties may file two separate documents by that date:

• Proposed corrections to the hearing transcript.
• Post-hearing briefs containing closing arguments, proposed findings of fact, and legal conclusions.

Neither filing is mandatory. The order specifies that parties will not be penalized for declining to participate and that the absence of a filing simply indicates no submission was intended.

For operators and investors following the proceeding, Aug. 17 should be viewed as the close of the briefing phase—not as the date the DEA will decide marijuana’s scheduling status.

Why Written Briefs Matter

One of the more significant details in Judge Julius’ order explains why these filings carry added importance.

Because “no time was allotted for closing arguments” during the hearings, the judge directed designated parties to use their post-hearing briefs to present their closing arguments and address any issues identified during the proceedings.

Each designated party is limited to a single brief of no more than 50 pages unless the tribunal grants permission for a longer filing upon a showing of good cause. The briefs must also comply with formatting requirements, including double spacing, 12-point font, and one-inch margins.

For many participants, these written submissions will serve as their final opportunity to persuade the administrative law judge before he prepares his recommendation.

The Transcript Still Isn’t Official

Although participants have already received daily copies of the hearing transcript, the record remains provisional.

Judge Julius ordered that designated parties may submit proposed corrections to address transcription errors, such as incorrectly attributed speakers or misspelled names. The tribunal will also conduct its own review before creating a final list of approved corrections.

Once that review is complete, the tribunal will issue an order adopting the final corrections, and the fully corrected transcript will be published on the DEA’s website as the official administrative record.

What Happens After August 17?

The conclusion of the post-hearing briefing does not immediately trigger a final rescheduling decision.

Instead, Judge Julius will review the hearing record, transcript, and post-hearing briefs before issuing a recommended decision to the DEA Administrator. That recommendation is advisory rather than final.

DEA Administrator Terrance Cole will ultimately determine whether to adopt, modify, or reject the recommendation as part of the agency’s rulemaking process.

Neither the Controlled Substances Act nor Judge Julius’ order establishes a deadline for either the recommendation or the Administrator’s final decision.

Why the Process Still Matters for Cannabis Businesses

Although the public hearings have concluded, the administrative process remains active.

For operators, investors, and other stakeholders, the next phase will shape the legal and factual record upon which the DEA ultimately bases its decision. The written briefs will consolidate the parties’ legal arguments, while the finalized transcript will become the official record supporting any future agency action—and potentially any subsequent judicial review.

While the industry’s attention has largely focused on the hearing testimony itself, the procedural steps now underway will determine how that testimony is evaluated before the DEA reaches one of the most consequential federal cannabis policy decisions in decades.

As the DEA evaluates the administrative record, cannabis businesses should continue monitoring developments that could affect compliance, investment, taxation, and capital markets. Join us at IgniteIt’s Cannabis Capital Summit in Washington, D.C., on November 18, where legal experts, operators, investors, and policymakers will discuss the evolving federal landscape and what the next phase of cannabis reform could mean for the industry.